Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial
Muhammad Raza Shah, Samreen Fatima, Sehrosh Naz Khan, Shafiullah, Gulshan Himani, Kelvin Wan, Timothy Lin, Johnson Y.N. Lau, Qingquan Liu, Dennis S.C. Lam
doi: https://doi.org/10.1101/2022.05.16.22275074
Muhammad Raza Shah
1Center for Bioequivalence Studies and Clinical Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270
Samreen Fatima
1Center for Bioequivalence Studies and Clinical Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270
Sehrosh Naz Khan
1Center for Bioequivalence Studies and Clinical Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270
Shafiullah
1Center for Bioequivalence Studies and Clinical Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270
Gulshan Himani
2The Indus Hospital Karachi, Plot C-76, Sector 31/5, Opposite Korangi Crossing, Darussalam Society Sector 39, Karachi, Sindh, Pakistan
Kelvin Wan
3Hong Kong Alliance of Integrated Medicine Against Covid, Hong Kong
Timothy Lin
3Hong Kong Alliance of Integrated Medicine Against Covid, Hong Kong
Johnson Y.N. Lau
4School of Chinese Medicine of Hong Kong, Baptist University, Hong Kong
Qingquan Liu
5Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People’s Republic of China
Dennis S.C. Lam
3Hong Kong Alliance of Integrated Medicine Against Covid, Hong Kong
4School of Chinese Medicine of Hong Kong, Baptist University, Hong Kong
Posted May 20, 2022.
Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial
Muhammad Raza Shah, Samreen Fatima, Sehrosh Naz Khan, Shafiullah, Gulshan Himani, Kelvin Wan, Timothy Lin, Johnson Y.N. Lau, Qingquan Liu, Dennis S.C. Lam
medRxiv 2022.05.16.22275074; doi: https://doi.org/10.1101/2022.05.16.22275074
Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial
Muhammad Raza Shah, Samreen Fatima, Sehrosh Naz Khan, Shafiullah, Gulshan Himani, Kelvin Wan, Timothy Lin, Johnson Y.N. Lau, Qingquan Liu, Dennis S.C. Lam
medRxiv 2022.05.16.22275074; doi: https://doi.org/10.1101/2022.05.16.22275074
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2340)
- Dermatology (205)
- Emergency Medicine (375)
- Epidemiology (11708)
- Forensic Medicine (10)
- Gastroenterology (695)
- Genetic and Genomic Medicine (3696)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2376)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3456)
- Nursing (195)
- Nutrition (520)
- Oncology (1805)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (416)
- Public and Global Health (6094)
- Radiology and Imaging (1263)
- Respiratory Medicine (822)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)